CDR-SB

There are 40 papers on CDR-SB in aging research: 6 trials and 31 observational studies in people, 1 review. The newest story, Nov 2, 2026: “Frailty linked to faster decline during lecanemab therapy”.

Biomarker

40 papers study it48 more mention it8 findings

6 new papers in 30 daysSee all 88 papers on CDR-SB

“The receiver operating characteristic (ROC) analysis showed that the area under the curve (AUC) values of the test groups were 0.85, 0.90, and 0.92 for discriminating NC from SCD, SCD from MCI, and MCI from dementia, respectively.”
Operational Determination of Subjective Cognitive Decline, Mild Cognitive Impairment, and Dementia Using Sum of Boxes of the Clinical Dementia Rating ScaleFrontiers in aging neuroscience2021doi:10.3389/fnagi.2021.705782
  • Human trial6
  • Humans31
  • In silico2

Associations

8

Metformin

downin humans1

1 study
  1. Metformin is associated with CDR-SB in humans (Participants with diabetes in NACC; metformin users compared with non-users) (CDR-SB RC −0.73, 95% CI −1.07 to −0.38).

    HumansParticipants with diabetes in NACC; metformin users compared with non-usersn = 2,443

More on Metformin

BrainAGE

upin humans1

1 study
  1. BrainAGE is associated with CDR-SB in humans (⍴ = 0.403).

    Humansbrain

    Generated blood-volume maps improve brain age estimates

    Brain communications

More on BrainAGE

Alzheimer's disease

upin humans1

1 study
  1. CDR-SB predicts Alzheimer's disease in humans (AD screening) (98.2% sensitivity, 99.6% specificity).

    HumansAD screeningn = 1,600

More on Alzheimer's disease

Reversion to normal cognition

downin humans1

1 study
  1. CDR-SB predicts reversion to normal cognition in humans (Baseline CDR < 1) (Reversion rates 12.5%, 5.6%, 0.9%, and 0% for scores 0.5, 1.0–2.0, 2.5–3.5, and ≥4.0, respectively).

    HumansBaseline CDR < 1n = 1,827

Conversion to dementia

upin humans1HR 5.22

1 study
  1. CDR-SB predicts conversion to dementia in humans (Baseline CDR < 1; CDR-SB ≥4.5 compared with CDR-SB 0) (HR 5.22 for CDR-SB ≥4.5 versus 0).

    HumansBaseline CDR < 1; CDR-SB ≥4.5 compared with CDR-SB 0n = 1,827

More on Conversion to dementia

Dementia

upin humans1

1 study
  1. CDR-SB predicts dementia in humans (discriminating MCI from dementia) (AUC 0.92).

    Humansdiscriminating MCI from dementian = 6,946

More on Dementia

Mild cognitive impairment

upin humans1

1 study
  1. CDR-SB predicts mild cognitive impairment in humans (discriminating SCD from MCI) (AUC 0.90).

    Humansdiscriminating SCD from MCIn = 6,946

More on Mild cognitive impairment

Subjective cognitive decline

upin humans1

1 study
  1. CDR-SB predicts subjective cognitive decline in humans (discriminating NC from SCD) (AUC 0.85).

    Humansdiscriminating NC from SCDn = 6,946

More on Subjective cognitive decline

Latest

Dec 2025: 8Jan 2026: 5Feb 2026: 4Mar 2026: 2Apr 2026: 0May 2026: 1Jun 2026: 7Jul 2026: 2Aug 2026: 1Sep 2026: 4Oct 2026: 10Nov 2026: 347 papers in 12 months
Aging and Disease

Frailty linked to faster decline during lecanemab therapy

Patients with physical frailty worsened 1.52 points per year faster on a dementia severity scale than those without frailty while receiving lecanemab.Patients with physical frailty worsened 1.52 points per year faster on a dementia severity scale than those without frailty while receiving lecanemab.

Cohort · 187 peopleBiomarkers
Alzheimer's & Dementia

Alzheimer’s tissue changes had varying links to thinking ability

Alzheimer’s tissue changes were associated with 9.09-point higher dementia ratings in unfavorable social profiles, versus 6.39-point higher ratings in favorable profiles.Alzheimer’s tissue changes were associated with 9.09-point higher dementia ratings in unfavorable social profiles, versus 6.39-point higher ratings in favorable profiles.

Cohort study of 1,193 peopleAlzheimer's disease
Brain Communications

Generated blood-volume maps improve brain age estimates

Among cognitively normal controls, average age-estimation error was 3.95 years with the combined model, versus 4.10 years using structural scans alone.Among cognitively normal controls, average age-estimation error was 3.95 years with the combined model, versus 4.10 years using structural scans alone.

Computational studyBiomarkers

See all 88 papers on CDR-SB